aamc.org does not support this web browser.

Advocacy & Policy

The Association of American Medical Colleges (AAMC) works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Through policies that affect health care delivery, research, education, health equity, and more, the federal government is a key partner in sustaining the vitality of the nation’s academic medicine ecosystem, which is essential to improving the health of all. Learn more about the AAMC’s priorities for the 118th Congress.

Diverse group of doctors stacking hands in an operating room table.

Statement on Improving Health Through DEI

The AAMC and other health care and medical associations made a statement in support of DEI policies in health care, to help improve our nation’s health.

Learn more

AAMC Policy and Priorities

microscope

Research

AAMC-member institutions endeavor to prepare a diverse medical research workforce and champion an environment where medical discovery can flourish. This strong commitment is key to innovation that benefits patients.

Explore Research Priorities

doctor in a coat

Clinical Care

AAMC-member teaching hospitals and faculty physicians cultivate and provide high-quality health care, especially for complex and vulnerable patients -- many of whom are unable to receive care elsewhere.

Explore Clinical Care Priorities

Doctor talking to mother and son at community outreach program

Investing in Healthier Communities

Academic medical centers serve at the crossroads of community health, health equity, and population health and are actively working to prevent and address persistent public health challenges.

Explore Healthier Communities

two doctors

Workforce

AAMC-member medical schools and teaching hospitals play a crucial role in preparing future physicians who help create a healthier future for all with innovative graduate medical education.

Explore Workforce Priorities

Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe

Find Advocacy & Policy Content

  • Recent
  • Relevance

Filter Results

Date
Custom Date Range
Date format: MM/DD/YYYY
Topic
1 - 10 of 33 results
Testimony & Correspondence FDA - Food & Drug Administration
Testimony & Correspondence

AAMC submitted an amicus brief to the U.S. Supreme Court in support of the petitioners in the case of FDA v the Alliance for Hippocratic Medicine

  • Jan. 30, 2024
  • PDF
Testimony & Correspondence

The AAMC submitted comments to the FDA on the agency's third patient focused drug development draft guidance.

  • Sept. 27, 2022
  • PDF
Testimony & Correspondence

The AAMC submitted comments to the FDA on the Draft Guidance on Diversity Plans to Improve Enrollment of Participants from Underrepresented Populations

  • June 13, 2022
  • PDF
Testimony & Correspondence

The AAMC was one of 100 stakeholders that signed a letter to Senate HELP leaders expressing concern with the VALID Act and its proposal for FDA regulations

  • June 13, 2022
  • PDF
Testimony & Correspondence

The AAMC joined nearly 75 organizations in a letter to the Senate HELP Committee urging inclusion of provisions to work to diversify clinical trials in the comm

  • June 8, 2022
  • PDF
Testimony & Correspondence

The AAMC sent a June 2 letter to HELP Committee leaders outlining concerns with the proposed regulation of LDTs in the VALID Act.

  • June 2, 2022
  • PDF
Testimony & Correspondence

The AAMC joined nearly 100 stakeholders in a letter to HELP Committee leaders expressing concern about the VALID Act of 2022.

  • May 31, 2022
  • PDF
Testimony & Correspondence

The AAMC joined over 70 stakeholders in a letter to HELP Committee leaders expressing concern about the VALID Act of 2022

  • May 22, 2022
  • PDF
Testimony & Correspondence

The AAMC submitted comments to the Senate HELP Committee in response to release of the PREVENT Pandemics Act discussion draft.

  • Feb. 4, 2022
  • PDF
Testimony & Correspondence

AAMC President and CEO Dr. David Skorton sent a Feb. 2 letter to Senators urging their support for the nomination of Dr. Robert Califf to be the next FDA commis

  • Feb. 2, 2022
  • PDF
The east side of the US Capitol in the early morning.

AAMC Champion of Academic Medicine Award

This award recognizes members of Congress and staff for extraordinary leadership in support of the academic medicine community.

Learn more

Advocacy Coalitions

The Ad Hoc Group for Medical Research supports enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH.

The GME Advocacy Coalition (GMEAC) is a group of organizations dedicated to the expansion and preservation of Medicare-supported graduate medical education.

The HPNEC advocates for continued support for the health professions and nursing workforce development programs critical to providing continued services to underserved and minority communities.

The FOVA is a diverse coalition representing national academic, medical, and scientific societies; voluntary health and patient advocacy groups; and veteran-focused associations.

Questions for the Office of Government Relations?

Email Us
AAMC Action

AAMC Action – Let’s Raise Our Voices Together

We are a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us